The previous page is sending you to https://www.prnewswire.com/news-releases/imprimis-pharmaceuticals-patent-pending-dropless-and-lessdrops-formulations-exceed-one-million-patient-eyes-milestone-300495036.html.

 If you do not want to visit that page, you can return to the previous page.